Douglas Tsao
Recent Articles
New Drug for Major Depressive Disorder Gets Good Surprise 03/10/2025
When a key competitor drops out, this treatment moves to top runner position; the biopharma behind it offers 1,084% upside, noted an H.C. Wainwright & Co. report.
Due to permission requirements, not all quotes are shown.
